Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 18c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.20), $0.18 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) In Lead To Buy Ultra Maritime For ~$3.5B - FT
• Con Edison adds lawyer Tali Farhadian to its board of directors
• TD SYNNEX launches €650 million European receivables securitization